Navigation Links
Benefit of exenatide has not yet been proven
Date:10/17/2007

ocedure is less time-consuming. The rapid report primarily serves to allow the Federal Joint Committee and other organisations involved to form an opinion. This report is usually not suitable to serve as a basis for policy-making decisions, as a submission of comments on the report prior to publication is not intended.

Background: exenatide

Exenatide is an incretin mimetic, i.e. it mimics the effects of an incretin produced in the body, GLP-1. Incretins are hormones that are produced in the gastrointestinal tract. In the pancreas, they stimulate insulin secretion and inhibit glucagon secretion, depending on the blood glucose level. In addition, they affect gastric as well as brain functions: they delay the emptying of the stomach and increase the feeling of satiety. In the body, the incretin GLP-1 is degraded by an enzyme, which is why the hormone itself is not a suitable drug. In the early 1990s, researchers discovered a hormone in the saliva of the North-American Gila monster; this hormone has a very similar structure to GLP-1, but is not degraded as rapidly in the human body. They further developed this original substance to the drug exenatide. Exenatide was approved in April 2005 in the USA as the first drug of this new drug class, and approved in Europe in November 2006. The manufacturer Eli Lilly introduced exenatide onto the German market in May 2007.


'/>"/>

Contact: Anna-Sabine Ernst
anna-sabine.ernst@iqwig.de
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. India to benefit from pharma companies move
2. Evaluating The Risks and Benefits of Hormone Therapy
3. Right attitude makes you benefit from exercise
4. Benefit of colonoscopy
5. How do patients benefit of clinical trials
6. The earlier the treatment, the more the benefit
7. Women benefit from consuming fish
8. Possible benefits of Hormone Replacement Therapy
9. Approaching through Telemedicine benefits patients
10. Hormone therapy provides no heart benefit
11. Benefits in fertility procedures
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Al Novak Elected Chairman of the Board of OrbusNeich Medical 2Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 1Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 2Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 3Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 4Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 5New Reagents from New England Biolabs Bring Purity and Increased Value to Sample Prep for Next Generation Sequencing 57976 1Advantage Business Media Launches Enhanced Websites 57972 1Advantage Business Media Launches Enhanced Websites 57972 2Advantage Business Media Launches Enhanced Websites 57972 3